Skip to menu Skip to content Skip to footer

2023

Journal Article

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales

Tamma, Pranita D., Harris, Patrick N. A., Mathers, Amy J., Wenzler, Eric and Humphries, Romney M. (2023). Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales. Clinical Infectious Diseases, 77 (11), 1585-1590. doi: 10.1093/cid/ciac688

Breaking Down the Breakpoints: Rationale for the 2022 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Enterobacterales

2023

Conference Publication

Elizabethkingia species: an emerging cause of healthcare-associated bloodstream infection among immunocompromised hosts

Stewart, Adam, Laupland, Kevin, Edwards, Felicity, Paterson, David and Harris, Patrick N. A. (2023). Elizabethkingia species: an emerging cause of healthcare-associated bloodstream infection among immunocompromised hosts. IDWeek 2023, Boston, MA USA, 11-15 October 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofad500.310

Elizabethkingia species: an emerging cause of healthcare-associated bloodstream infection among immunocompromised hosts

2023

Conference Publication

Assessment of in vitro synergy between piperacillin-tazobactam-meropenem and imipenem-meropenem against OXA-48 producing Klebsiella pneumoniae using time-kill assays

Demir, Mervenur, Aslan, Abdullah Tarik, Seren Tanrıverdi, Elif, Otlu, Barış, Akova, Murat, Paterson, David, Harris, Patrick N. A. and Hazırolan, Gülşen (2023). Assessment of in vitro synergy between piperacillin-tazobactam-meropenem and imipenem-meropenem against OXA-48 producing Klebsiella pneumoniae using time-kill assays. IDWeek 2023, Boston, MA USA, 11-15 October 2023. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ofid/ofad500.2357

Assessment of in vitro synergy between piperacillin-tazobactam-meropenem and imipenem-meropenem against OXA-48 producing Klebsiella pneumoniae using time-kill assays

2023

Conference Publication

A comparison of low-level to high-level disinfection in eliminating microorganisms from ultrasound transducers used on skin: a non-inferiority randomised controlled trial

Peters, Nathan, Williamson, Frances, Bauer, Michelle, Llewellyn, Stacey, Snelling, Peter, Marsh, Nicole, Harris, Patrick, Stewart, Adam and Rickard, Claire (2023). A comparison of low-level to high-level disinfection in eliminating microorganisms from ultrasound transducers used on skin: a non-inferiority randomised controlled trial. 2023 ACIPC International Conference, Adelaide, SA Australia, 12-15 November 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.idh.2023.09.002

A comparison of low-level to high-level disinfection in eliminating microorganisms from ultrasound transducers used on skin: a non-inferiority randomised controlled trial

2023

Journal Article

The opportunities and challenges for artificial intelligence to improve sepsis outcomes in the paediatric intensive care unit

Aslan, Abdullah Tarik, Permana, Budi, Harris, Patrick N. A., Naidoo, Kuban D., Pienaar, Michael A. and Irwin, Adam D. (2023). The opportunities and challenges for artificial intelligence to improve sepsis outcomes in the paediatric intensive care unit. Current Infectious Disease Reports, 25 (11), 243-253. doi: 10.1007/s11908-023-00818-4

The opportunities and challenges for artificial intelligence to improve sepsis outcomes in the paediatric intensive care unit

2023

Journal Article

Bugs in floods

Blaskovich, Mark A. T. and Harris, Patrick N. A. (2023). Bugs in floods. Microbiology Australia, 44 (4), 176-180. doi: 10.1071/ma23051

Bugs in floods

2023

Journal Article

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors

Gassiep, Ian, Burnard, Delaney, Permana, Budi, Bauer, Michelle J., Cuddihy, Thom, Forde, Brian M., Chatfield, Mark D., Ling, Weiping, Norton, Robert and Harris, Patrick N. A. (2023). Melioidosis Queensland: an analysis of clinical outcomes and genomic factors. PLoS Neglected Tropical Diseases, 17 (10) e0011697, 1-13. doi: 10.1371/journal.pntd.0011697

Melioidosis Queensland: an analysis of clinical outcomes and genomic factors

2023

Journal Article

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

2023

Journal Article

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review

Aslan, Abdullah Tarık, Ezure, Yukiko, Horcajada, Juan Pablo, Harris, Patrick N. A. and Paterson, David L. (2023). In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Frontiers in Medicine, 10 1249030, 1-16. doi: 10.3389/fmed.2023.1249030

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review

2023

Journal Article

Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy

Stewart, Adam G., Heney, Claire, Paterson, David L., Harris, Patrick N.A., Edwards, Felicity and Laupland, Kevin B. (2023). Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy. Internal Medicine Journal, 53 (8), 1489-1491. doi: 10.1111/imj.16198

Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy

2023

Journal Article

Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints

Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem, Akova, Murat ... Harris, Patrick N. A. (2023). Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints. Infectious Diseases, 55 (9), 607-613. doi: 10.1080/23744235.2023.2226709

Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints

2023

Journal Article

Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial

Rogers, Benjamin A., Fowler, Robert, Harris, Patrick N. A., Davis, Joshua S., Pinto, Ruxandra L., Bhatia Dwivedi, Dhiraj, Rishu, Asgar, Shehabi, Yahya and Daneman, Nick (2023). Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial. BMJ Open, 13 (6) e069708. doi: 10.1136/bmjopen-2022-069708

Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial

2023

Journal Article

Comparison of low‐level to high‐level disinfection in eliminating microorganisms from ultrasound transducers used on skin : a noninferiority randomized controlled trial

Peters, Nathan, Williamson, Frances, Bauer, Michelle J., Llewellyn, Stacey, Snelling, Peter J., Marsh, Nicole, Harris, Patrick N. A., Stewart, Adam G. and Rickard, Claire M. (2023). Comparison of low‐level to high‐level disinfection in eliminating microorganisms from ultrasound transducers used on skin : a noninferiority randomized controlled trial. Journal of Ultrasound in Medicine, 42 (11), 2525-2534. doi: 10.1002/jum.16286

Comparison of low‐level to high‐level disinfection in eliminating microorganisms from ultrasound transducers used on skin : a noninferiority randomized controlled trial

2023

Journal Article

Using genomics to investigate an outbreak of vancomycin-resistant Enterococcus faecium ST78 at a large tertiary hospital in Queensland

Permana, Budi, Harris, Patrick N. A., Runnegar, Naomi, Lindsay, Margaret, Henderson, Belinda C., Playford, E. G., Paterson, David L., Beatson, Scott A. and Forde, Brian M. (2023). Using genomics to investigate an outbreak of vancomycin-resistant Enterococcus faecium ST78 at a large tertiary hospital in Queensland. Microbiology Spectrum, 11 (3) e0420422, 1-10. doi: 10.1128/spectrum.04204-22

Using genomics to investigate an outbreak of vancomycin-resistant Enterococcus faecium ST78 at a large tertiary hospital in Queensland

2023

Journal Article

Deconstructing the 2023 Clinical and Laboratory Standards revised piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa

Tamma, Pranita D., Harris, Patrick N. A., Mathers, Amy J., Wenzler, Eric and Humphries, Romney M. (2023). Deconstructing the 2023 Clinical and Laboratory Standards revised piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa. Clinical Infectious Diseases, 76 (10), 1868-1870. doi: 10.1093/cid/ciad012

Deconstructing the 2023 Clinical and Laboratory Standards revised piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa

2023

Journal Article

Expanding the geographic boundaries of Melioidosis in Queensland, Australia

Gassiep, Ian, Grey, Victoria, Thean, Li Jun, Farquhar, Drew, Clark, Julia E., Ariotti, Lawrence, Graham, Rikki, Jennison, Amy V., Bergh, Haakon, Anuradha, Satyamurthy, Dyer, Wendy, James, Christian, Huang, Andrea, Putt, Elise, Pakeerathan, Veenaa, Griffin, Paul M. and Harris, Patrick N. A. (2023). Expanding the geographic boundaries of Melioidosis in Queensland, Australia. The American Journal of Tropical Medicine and Hygiene, 108 (6), 1215-1219. doi: 10.4269/ajtmh.23-0002

Expanding the geographic boundaries of Melioidosis in Queensland, Australia

2023

Journal Article

In vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial

Stewart, Adam G., Bauer, Michelle J., Butkiewicz, Dominika, Hinton, Alexandra, Henderson, Andrew, Harris, Patrick N.A. and Paterson, David L. (2023). In vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial. International Journal of Antimicrobial Agents, 62 (2) 106858, 1-4. doi: 10.1016/j.ijantimicag.2023.106858

In vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial

2023

Journal Article

Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019

Laupland, Kevin B., Edwards, Felicity, Furuya-Kanamori, Luis, Paterson, David L. and Harris, Patrick N. A. (2023). Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019. The American Journal of Medicine, 136 (9), 896-901. doi: 10.1016/j.amjmed.2023.05.003

Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019

2023

Journal Article

Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification

Ertl, Nicole G., Irwin, Adam D., Macdonald, Joanne, Bauer, Michelle J., Wang, Claire Y. T., Harris, Patrick N. A., Heney, Claire, Zowawi, Hosam M. and Whiley, David M. (2023). Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification. JAC - Antimicrobial Resistance, 5 (2) dlad023, dlad023. doi: 10.1093/jacamr/dlad023

Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification

2023

Journal Article

A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses

Dong, Xiaomin, Deng, Yi-Mo, Aziz, Ammar, Whitney, Paul, Clark, Julia, Harris, Patrick, Bautista, Catherine, Costa, Anna-Maria, Waller, Gregory, Daley, Andrew J, Wieringa, Megan, Korman, Tony and Barr, Ian G. (2023). A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses. Journal of Clinical Virology, 161 105423, 1-6. doi: 10.1016/j.jcv.2023.105423

A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses